Bioengineering & Digital Health



Research Unit Analytical Pathology (AAP)

Head: Prof. Dr. Axel Walch

The independent Research  Unit Analytical Pathology Department (AAP) carries out scientific development, as a complement to research units with a clinical and fundamental orientation, of translational research on diseases that occur in tissue. AAP is involved in the translation of (for example) in-vitro models or animal models to application in humans. AAP thus links basic research with diagnostic application, subsequently translating the findings of experimental and molecular pathology into procedures for the classification of diseases and predictive diagnostics dealing with tissue.

To the AAP website

Institute of AI for Health (AIH)

Director: Dr. Carsten Marr

The Institute of AI for Health (AIH) develops solutions for digital health challenges. As an emerging European hub for applied artificial intelligence (AI) and machine learning (ML), we aim at modeling disease kinetics, mining electronic health records, developing new drugs and treatments, analyzing biomedical images, and integrating multi-omics data for precision medicine.

To the AIH website
To the website Helmholtz AI - Artificial Intelligence Cooperation Unit

Institute of Biological and Medical Imaging (IBMI)

Director: Prof. Dr. Vasilis Ntziachristos
Chair of Biological Imaging at Technische Universität München

The Institute of Biological and Medical Imaging (IBMI) researches in vivo imaging technologies for biosciences. It develops systems, theories and methods for imaging and image reconstruction as well as animal models for the interrogation of new technologies at the biological, pre-clinical and clinical level. The aim of this research is to provide innovative tools for the biomedical laboratory, for diagnostics and disease monitoring and for the treatment of human diseases.

To the IBMI website

Institute of Computational Biology (ICB)

Director: Prof. Dr. Dr. Fabian Theis
Chair of Mathematical Modeling of Biological Systems at Technische Universität München

The Institute of Computational Biology (ICB) develops and applies methods for the model-based description of biological systems, using a data-driven approach by integrating information on multiple scales ranging from single-cell time series to large-scale omics. Given the fast technological advances in molecular biology, their aim is to provide and collaboratively apply innovative tools with experimental groups in order to jointly advance our understanding and treatment of common human diseases.

To the ICB website

Institute of Machine Learning in Biomedical Imaging (IML)

Director: Prof. Dr. Julia Anna Schnabel

The Institute of Machine Learning in Biomedical Imaging (IML) focuses on research to leverage machine learning for the grand challenges in biomedical imaging in areas of unmet clinical need. Its goal is to fundamentally transform the use of imaging for diagnostics and prognostics. Novel and affordable solutions should empower clinics to make more accurate, fast and reliable decisions for early detection, treatment planning and improved patient outcome.

Link to the IML website

Institute of Neurogenomics (ING)

Director: Prof. Dr. Juliane Winkelmann
Chair of Neurogenomics at Technische Universität München

At the Institute of Neurogenomics (ING), the focus is on the genetic basis of neurological diseases. The research concentrates on the underlying genomic architecture and the molecular mechanisms of complex genetic as well as rare neurological diseases. The objective is to investigate the genetic basis of neurological diseases in order to improve diagnosis and ultimately make it possible to offer patients tailored, personalized treatment.

To the ING website

Institute for Synthetic Biomedicine (ISBM)

Director: Prof. Dr. Gil Gregor Westmeyer

Professor of Neurobiological Engineering at Technical University Munich (TUM)  

The Institute for Synthetic Biomedicine (ISBM) develops and deploys next-generation biotechniques for molecular sensing and actuation of distributed cellular processes to reverse engineer cell-circuit function and guide future cell therapies. The research of ISBM focuses on three synergistic areas: (1) biomolecular engineering of sensors and actuators, (2) genetic and cellular engineering of model systems, and (3) multiscale interrogation of cell-circuit function.

To the ISBM website

Institute for Tissue Engineering and Regenerative Medicine (ITERM)

Director: Dr. Ali Ertürk

A fundamental challenge in modern science is to understand how the brain functions in health and disease. The Institute for Tissue Engineering and Regenerative Medicine (ITERM) is interested in elucidating the mechanisms leading to neurological diseases and ageing, in particular stroke and dementia. To this end, it develops and implements 3D imaging technologies to be able to generate the highest resolution views of intact rodent organs and bodies. It developed DISCO line of organic solvent tissues clearing methods, which have been a great utility for scientists from diverse bio-medical research fields.

To the ITERM website

Institute of Translational Genomics (ITG)

Director: Prof. Dr. Eleftheria Zeggini

The research of the Institute of Translational Genomics (ITG) leverages big data in genetics and genomics for medically important human traits. It aims to translate insights from genomics into mechanisms of disease development and progression, shortening the path to translation and empowering precision medicine.

To the ITG website